Rilonacept

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 269 publications

Interleukin-1: from discovery to therapeutic targeting of the first cytokine.

Interleukin-1: from discovery to therapeutic targeting of the first cytokine.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: March 02, 2026

Targeting cytokine pathways: the role of biologics in autoinflammatory disorders.

Targeting cytokine pathways: the role of biologics in autoinflammatory disorders.

Journal: Expert review of clinical immunology

Published: February 01, 2026

Comment on "Risk of Pericarditis Recurrence Associated With Rilonacept and NSAID/Colchicine Therapy After Initial Pericarditis Presentation: A Retrospective Real-World Comparative Risk Analysis With TriNetX".

Comment on "Risk of Pericarditis Recurrence Associated With Rilonacept and NSAID/Colchicine Therapy After Initial Pericarditis Presentation: A Retrospective Real-World Comparative Risk Analysis With TriNetX".

Journal: American journal of therapeutics

Published: January 29, 2026

Biological Therapies for Urate Lowering and Inflammation Control in Gout Management.

Biological Therapies for Urate Lowering and Inflammation Control in Gout Management.

Journal: Journal of inflammation research

Published: December 31, 2025

Mechanistic Insights and Emerging Therapeutic Strategies in Recurrent Pericarditis.

Mechanistic Insights and Emerging Therapeutic Strategies in Recurrent Pericarditis.

Journal: Methodist DeBakey cardiovascular journal

Published: December 12, 2025

Idiopathic pericarditis in 2025: Advances in diagnosis and therapeutic strategies.

Idiopathic pericarditis in 2025: Advances in diagnosis and therapeutic strategies.

Journal: Autoimmunity reviews

Published: November 29, 2025

Risk of Pericarditis Recurrence Associated With Rilonacept and NSAID/Colchicine Therapy After Initial Pericarditis Presentation: A Retrospective Real-World Comparative Risk Analysis With TriNetX.

Risk of Pericarditis Recurrence Associated With Rilonacept and NSAID/Colchicine Therapy After Initial Pericarditis Presentation: A Retrospective Real-World Comparative Risk Analysis With TriNetX.

Journal: American journal of therapeutics

Published: November 11, 2025

Disproportionality Analysis of Adverse Events Associated with IL-1 Inhibitors in the FDA Adverse Event Reporting System (FAERS).

Disproportionality Analysis of Adverse Events Associated with IL-1 Inhibitors in the FDA Adverse Event Reporting System (FAERS).

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 17, 2025

Interleukin-1 receptor type 1 in pancreatic cancer progression and metastasis: a review.

Interleukin-1 receptor type 1 in pancreatic cancer progression and metastasis: a review.

Journal: International journal of clinical oncology

Published: September 23, 2025

Pericarditis at the crossroads: Unlocking the next wave of therapies.

Pericarditis at the crossroads: Unlocking the next wave of therapies.

Journal: International journal of cardiology. Heart & vasculature

Published: September 15, 2025

Interleukin-1 Inhibitors for Management of Recurrent Pericarditis After Thoracic Organ Transplantation.

Interleukin-1 Inhibitors for Management of Recurrent Pericarditis After Thoracic Organ Transplantation.

Journal: JACC. Case reports

Published: August 26, 2025

Use of an IL-1 Inhibitor for Refractory Steroid-Dependent Lupus Pericarditis With Constrictive Physiology.

Use of an IL-1 Inhibitor for Refractory Steroid-Dependent Lupus Pericarditis With Constrictive Physiology.

Journal: JACC. Case reports

Published: August 01, 2025

Showing 1-12 of 269

Last Updated: 04/28/2026